@misc{indiciaed613ae7a01d9,
  title = {Histone deacetylase activity limits the response to EZH2 inhibition-based therapy in epithelioid sarcoma and is targetable by epigenetic combination},
  author = {Arrighetti, N. and Soffientini, C. and Zuco, V. and Percio, S. and Cleris, L. and Abdulrazak Ahmed, S. and Del Savio, E. and Sigalotti, L. and Maestro, R. and Brich, S. and Dagrada, G. P. and Barisella, M. and Collini, P. and Kentsis, A. and Huang, P. H. and Gronchi, A. and Frezza, A. M. and Stacchiotti, S. and Zaffaroni, N. and Pasquali, S.},
  year = {2026},
  doi = {10.64898/2026.08.04.742011},
  url = {https://www.biorxiv.org/content/10.64898/2026.08.04.742011v1},
  note = {Source identifier: 10.64898/2026.08.04.742011}
}